Renowned Fortune 500 CEO Joins Kraig Advisory Board
LANSING, MI–November 9, 2010- Kraig Biocraft Laboratories, Inc. (KBLB) announced today that Henry Wendt, the renowned former head of SmithKline Beecham, has joined the Company’s Board of Advisors.
Wendt is the former CEO and Chairman of SmithKline Beecham, one of the world’s largest and most successful corporations. He has an unparalleled track record for fostering and managing corporate growth through mergers and acquisitions, as well as through organic growth and global marketing. In fact, he is generally recognized as the principal architect of the successful merger which created SmithKline Beecham.
“Henry Wendt is one of the top CEOs on the planet, with a proven Fortune 500 track record,” said Kraig Biocraft Laboratories CEO, Kim K. Thompson. “In addition to his groundbreaking leadership at SmithKline Beecham, he literally wrote the book on successful strategies for corporate growth in the global marketplace. Mr. Wendt’s book Global Embrace: Corporate Challenges in a Transnational World is, in my opinion, a ‘must read’ for corporate executives. We are very fortunate and excited to have him on our team. I know that, as a member of our advisory board, his insight and advice will be invaluable, as we grow and commercialize our revolutionary technologies.”
Kraig Biocraft Laboratories is a fully reporting biotechnology company, which recently achieved a series of scientific breakthroughs with implications for the global textile industry.
To learn more about Kraig Biocraft Laboratories and its recent commercial and scientific breakthroughs please visit www.KraigLabs.com. The website hosts several short videos describing the Company’s recent commercial and technological breakthroughs and outlines the commercial potential that has garnered attention of many scientific and trade journals.
Statements in this press release about the company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “hopes,” “develops,” “researching,” “research,” “potential,” “implications,” “could” or other words or phrases of similar import. Similarly, statements in this release that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company’s financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.